Swiss pharma Roche has today officially launched a new institute that will focus on the use of human model systems – in vitro replicas of human tissues and organs – for dr
The undisputed star of Roche’s pharma portfolio in the first quarter of this year is eye disease therapy Vabysmo, heading for blockbuster territory after posting sales of
The FDA has set aside reservations it had about the use of Roche’s Polivy as a first-line treatment with chemotherapy for diffuse large B-cell lymphoma (DLBCL), and cleare
In a further sign of pharma embracing digital technologies, Roche has launched a library of medical algorithms designed to make clinical decision-making faster and more ta
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.